Publications by authors named "Satoko Uegaki"

The clinicopathological significance of carbohydrate antigen 19-9 (CA19-9) in gastric cancer (GC) remains obscure. Therefore, the current study aimed to clarify the clinicopathological value of CA19-9 in GC utilizing autopsy cases. We examined the expression of CA19-9 and mucin core proteins in GC immunohistochemically, and analyzed serum CA19-9 levels and clinicopathological variables or complications.

View Article and Find Full Text PDF

Aim: To determine the incidence and endoscopic types of colorectal lesions diagnosed with colonoscopy in elderly patients.

Methods: Consecutive Japanese patients who underwent colonic endoscopy between 1994 and 2007 (n = 5145; 2245 men and 2900 women, age 20-101 years) were examined retrospectively. Correlations between age, sex and number of lesions were analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • * Study examined 187 pancreatic and 49 colon cancer patients, analyzing their smoking and drinking habits alongside ALDH2 genotypes compared to age-matched controls.
  • * Findings indicate that inactive ALDH2 and smoking are risk factors for pancreatic cancer, but inactive ALDH2 does not appear to increase colon cancer risk.
View Article and Find Full Text PDF

Background/aims: Vitamin D receptor (VDR) agonists have recently been identified as potent immunomodulators capable of inhibiting Th1-mediated immune response, leading us to consider the hypothesis that functional VDR polymorphisms might contribute to enhanced risk for developing primary biliary cirrhosis (PBC), a Th1-mediated autoimmune disease. In the current study, we aimed at elucidating the genetic association of VDR polymorphisms with susceptibility to PBC in Japanese and Italian populations.

Methods: We enrolled 334 PBC patients (195 Japanese and 139 Italians), as well as 334 age- and sex-matched controls (179 Japanese and 156 Italians).

View Article and Find Full Text PDF

Benign recurrent intrahepatic cholestasis (BRIC) is an autosomal recessive disorder characterized by bouts of cholestasis that resolve spontaneously without leaving considerable liver damage. Most of BRIC patients have mutations in ATP8B1 gene coding FIC1 protein. It has been suggested that an imbalance between the gut absorption of bile acids and the liver excretion possibly causes the development of cholestasis.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to understand the molecular mechanisms behind cholangiocyte proliferation to improve treatments for cholestatic diseases, focusing on gene expression in bile duct ligated (BDL) rats.
  • - Using microarray analysis, researchers found 38 genes that were up-regulated and 17 that were down-regulated in the livers of BDL rats compared to sham-operated rats, with a marked increase in vascular endothelial growth factor (VEGF) levels at day 2 post-surgery.
  • - The up-regulated VEGF expression was mainly found in hepatocytes near portal tracts, suggesting its role in bile duct proliferation and indicating potential targets for treating cholestatic conditions.
View Article and Find Full Text PDF

Aim: To elucidate risk factors contributing to the development of hepatocellular carcinoma (HCC) among patients with sustained viral response (SVR) after interferon (IFN) treatment and to examine whether HCV-RNA still remained in the liver of SVR patients who developed HCC.

Methods: Two-hundred and sixty-six patients, who achieved SVR, were enrolled in this study. We retrospectively reviewed clinical, viral and histological features of the patients, and examined whether the development of HCC depends on several clinical variables using Kaplan-Meier Method.

View Article and Find Full Text PDF

It still remains unclear how antimitochondrial autoantibodies (AMA) are involved with immunopathogenesis of primary biliary cirrhosis (PBC). We have suggested the potential role of IgA-AMA in damage to epithelial cells in PBC. In the current study, we investigated whether IgA-AMA were detectable in sera and saliva of PBC patients, to examine the association between detectable IgA-type autoantibodies in sera or saliva and progression of liver diseases.

View Article and Find Full Text PDF

We report a patient with primary hypothyroidism, who developed hepatocellular injury due to levothyroxine, synthetic thyroxine. A 63-year-old male was admitted to our hospital due to elevation of liver enzymes. The patient was diagnosed as having hypothyroidism and had been treated with levothyroxine for almost two months until admission.

View Article and Find Full Text PDF